CGEN
Compugen Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.49
+1.22%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 32.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- 6.63x
- PEG TTM
- —
- Price / book
- 2.66x
- Price / sales
- 3.19x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $113.6M
- EV / sales
- 1.54x
- EV / EBITDA
- 3.22x
- EV / EBIT
- 3.75x
- Market cap
- $235.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026